BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Asselta R, Robusto M, Platé M, Santoro C, Peyvandi F, Duga S. Molecular characterization of 7 patients affected by dys- or hypo-dysfibrinogenemia: Identification of a novel mutation in the fibrinogen Bbeta chain causing a gain of glycosylation. Thromb Res 2015;136:168-74. [PMID: 26006300 DOI: 10.1016/j.thromres.2015.05.007] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
Number Citing Articles
1 Luo M, Deng D, Xiang L, Cheng P, Liao L, Deng X, Yan J, Lin F. Three cases of congenital dysfibrinogenemia in unrelated Chinese families: heterozygous missense mutation in fibrinogen alpha chain Argl6His. Medicine (Baltimore) 2016;95:e4864. [PMID: 27684817 DOI: 10.1097/MD.0000000000004864] [Cited by in Crossref: 39] [Cited by in F6Publishing: 2] [Article Influence: 7.8] [Reference Citation Analysis]
2 Yoda M, Kaido T, Taira C, Higuchi Y, Arai S, Okumura N. Congenital fibrinogen disorder with a compound heterozygote possessing two novel FGB mutations, one qualitative and the other quantitative. Thromb Res 2020;196:152-8. [PMID: 32871307 DOI: 10.1016/j.thromres.2020.08.031] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Simurda T, Zolkova J, Kolkova Z, Loderer D, Dobrotova M, Skornova I, Brunclíkova M, Grendar M, Lasabova Z, Stasko J, Kubisz P. Comparison of clinical phenotype with genetic and laboratory results in 31 patients with congenital dysfibrinogenemia in northern Slovakia. Int J Hematol 2020;111:795-802. [PMID: 32166693 DOI: 10.1007/s12185-020-02842-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
4 Xiang L, Luo M, Yan J, Liao L, Zhou W, Deng X, Deng D, Cheng P, Lin F. Combined use of Clauss and prothrombin time-derived methods for determining fibrinogen concentrations: Screening for congenital dysfibrinogenemia. J Clin Lab Anal 2018;32:e22322. [PMID: 28922493 DOI: 10.1002/jcla.22322] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
5 Richard M, Celeny D, Neerman-Arbez M. Mutations Accounting for Congenital Fibrinogen Disorders: An Update. Semin Thromb Hemost 2022. [PMID: 35073585 DOI: 10.1055/s-0041-1742170] [Reference Citation Analysis]
6 Simurda T, Brunclikova M, Asselta R, Caccia S, Zolkova J, Kolkova Z, Loderer D, Skornova I, Hudecek J, Lasabova Z, Stasko J, Kubisz P. Genetic Variants in the FGB and FGG Genes Mapping in the Beta and Gamma Nodules of the Fibrinogen Molecule in Congenital Quantitative Fibrinogen Disorders Associated with a Thrombotic Phenotype. Int J Mol Sci 2020;21:E4616. [PMID: 32610551 DOI: 10.3390/ijms21134616] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
7 Casini A, Brungs T, Lavenu-Bombled C, Vilar R, Neerman-Arbez M, de Moerloose P. Genetics, diagnosis and clinical features of congenital hypodysfibrinogenemia: a systematic literature review and report of a novel mutation. J Thromb Haemost 2017;15:876-88. [PMID: 28211264 DOI: 10.1111/jth.13655] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 6.2] [Reference Citation Analysis]
8 Kamijo T, Kaido T, Yoda M, Arai S, Yamauchi K, Okumura N. Recombinant γY278H Fibrinogen Showed Normal Secretion from CHO Cells, but a Corresponding Heterozygous Patient Showed Hypofibrinogenemia. Int J Mol Sci 2021;22:5218. [PMID: 34069309 DOI: 10.3390/ijms22105218] [Reference Citation Analysis]
9 Zhou N, Xu P, Zhou M, Xu Y, Li P, Chen B, Ouyang J, Zhou R. A novel fibrinogen variant: dysfibrinogenemia associated with γAsp185Asn substitution. J Thromb Thrombolysis 2017;44:139-44. [PMID: 28425010 DOI: 10.1007/s11239-017-1496-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
10 Bor MV, Feddersen S, Pedersen IS, Sidelmann JJ, Kristensen SR. Dysfibrinogenemia-Potential Impact of Genotype on Thrombosis or Bleeding. Semin Thromb Hemost 2021. [PMID: 34261148 DOI: 10.1055/s-0041-1730358] [Reference Citation Analysis]
11 Tajdar M, Orlando C, Casini A, Herpol M, De Bisschop B, Govaert P, Neerman-Arbez M, Jochmans K. Heterozygous FGA p.Asp473Ter (fibrinogen Nieuwegein) presenting as antepartum cerebral thrombosis. Thromb Res 2018;163:185-9. [PMID: 29122299 DOI: 10.1016/j.thromres.2017.10.020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
12 Gong X, Yuan B, Yuan Y. Congenital hypofibrinogenemia with recurrent thromboembolism: A clinical case report. Thrombosis Update 2022. [DOI: 10.1016/j.tru.2022.100099] [Reference Citation Analysis]
13 Zhang X, Zhang C, Wang B, Chen N, Sun G, Guo X. Congenital fibrinogen disorders with repeated thrombosis. J Thromb Thrombolysis 2020;49:312-5. [PMID: 31542854 DOI: 10.1007/s11239-019-01958-y] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
14 Dorgalaleh A, Farshi Y, Haeri K, Ghanbari OB, Ahmadi A. Risk and Management of Intracerebral Hemorrhage in Patients with Bleeding Disorders. Semin Thromb Hemost 2022. [PMID: 34991167 DOI: 10.1055/s-0041-1740566] [Reference Citation Analysis]